Global Zanamivir Market 2016 - GlaxoSmithKline, Simcere, Lunan Pharmaceutical

Zanamivir is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.

Download sample report at http://www.fiormarkets.com/report-detail/15370/request-sample

This report provides detailed analysis of worldwide markets for Zanamivir from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Zanamivir market and further lays out an analysis of the factors influencing the supply/demand for Zanamivir, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Global Zanamivir Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Zanamivir market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies.

Access full report at http://www.fiormarkets.com/report/global-zanamivir-market-outlook-2016-2021-15370.html

The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Zanamivir market are GlaxoSmithKline (UK), Simcere (China), Lunan Pharmaceutical (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Zanamivir industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com

This release was published on openPR.